Eiger BioPharmaceuticals所有资讯

Eiger BioPharmaceuticals | SC 13G：超过5%持股股东披露文件-Moshe Arkin(10.09%)

08/26 22:06

Eiger BioPharmaceuticals | SC 13D/A：超过5%持股股东披露文件(修正)-Moshe Arkin(3.58%)

07/01 18:49

Eiger BioPharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-Ameriprise Financial, Inc.(0.00%),Columbia Management Investment Advisers, LLC(0.00%)等

05/11 02:19

Eiger BioPharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-683 Capital Management, LLC(4.7%),683 Capital Partners, LP(4.7%)等

02/15 07:01

Eiger BioPharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-Ameriprise Financial, Inc.(16.91%),Columbia Management Investment Advisers, LLC(16.06%)等

02/14 23:57

Eiger BioPharmaceuticals | SC 13D/A：超过5%持股股东披露文件(修正)-Moshe Arkin(10.09%)

2023/12/04 19:01

Eiger BioPharmaceuticals | SC 13D：超过5%持股股东披露文件-Moshe Arkin(10.09%)

2023/11/24 19:01

Eiger BioPharmaceuticals | SC 13D/A：超过5%持股股东披露文件(修正)-Richard Kayne(12.13%),Propel Bio Management LLC(9.91%)等

2023/11/03 09:54

Eiger BioPharmaceuticals | 4：持股变动声明-股东 KAYNE RICHARD A

2023/11/03 09:21

Eiger BioPharmaceuticals | 4：持股变动声明-股东 KAWAS LEEN

2023/11/03 09:14

Eiger BioPharmaceuticals | 3：首次持股声明-股东 KAYNE RICHARD A

2023/10/31 04:53

Eiger BioPharmaceuticals | 3：首次持股声明-股东 KAWAS LEEN

2023/10/31 04:51

Eiger BioPharmaceuticals | SC 13D：超过5%持股股东披露文件-Richard Kayne(11.51%),Propel Bio Management LLC(9.86%)等

2023/10/21 04:29

Eiger BioPharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-Propel Bio Management LLC(10.9%),Leen Kawas(10.9%)等

2023/09/29 04:54

Eiger BioPharmaceuticals | 4：持股变动声明-高管 Choong Ingrid

2023/09/06 09:38

Eiger BioPharmaceuticals | 3：首次持股声明-高管 Choong Ingrid

2023/09/06 09:35

Eiger BioPharmaceuticals | SC 13G：超过5%持股股东披露文件-Propel Bio Management, LLC(5.40%),Leen Kawas(5.40%)

2023/08/15 18:00

Eiger BioPharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-BlackRock, Inc.(2.1%)

2023/07/08 04:35

Eiger BioPharmaceuticals | 4：持股变动声明-首席执行官 Apelian David

2023/07/07 05:37

Eiger BioPharmaceuticals | 4：持股变动声明-总法律顾问 Vollins James

2023/05/03 04:30